Pub. Date : 2017 Jul
PMID : 28770102
6 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | A predictive analysis of the SP120 and 10D7G2 antibodies for human equilibrative nucleoside transporter 1 (hENT1) in pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine. | gemcitabine | solute carrier family 29 member 1 (Augustine blood group) | Homo sapiens |
| 2 | A predictive analysis of the SP120 and 10D7G2 antibodies for human equilibrative nucleoside transporter 1 (hENT1) in pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine. | gemcitabine | solute carrier family 29 member 1 (Augustine blood group) | Homo sapiens |
| 3 | Expression of human equilibrative nucleoside transporter 1 (hENT1) in pancreatic ductal adenocarcinoma (PDAC) has been postulated to be a marker of sensitivity to gemcitabine. | gemcitabine | solute carrier family 29 member 1 (Augustine blood group) | Homo sapiens |
| 4 | Expression of human equilibrative nucleoside transporter 1 (hENT1) in pancreatic ductal adenocarcinoma (PDAC) has been postulated to be a marker of sensitivity to gemcitabine. | gemcitabine | solute carrier family 29 member 1 (Augustine blood group) | Homo sapiens |
| 5 | However, heterogeneity in the studies attempting to quantify hENT1 expression in patients with PDAC treated with gemcitabine has yielded inconclusive results that impede the adoption of hENT1 expression as a predictive biomarker. | gemcitabine | solute carrier family 29 member 1 (Augustine blood group) | Homo sapiens |
| 6 | These data suggest that either antibody for hENT1 can be used to predict gemcitabine sensitivity in resected PDAC. | gemcitabine | solute carrier family 29 member 1 (Augustine blood group) | Homo sapiens |